Neuroone Medical Technologies Corp
NASDAQ:NMTC
Neuroone Medical Technologies Corp
NASDAQ:NMTC
Price:
0.7375
USD
2.42%
Market Closed
Market Cap:
$37.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Neuroone Medical Technologies Corp
NASDAQ:NMTC
|
US |
|
Nemaura Medical Inc
F:N18A
|
US |
|
Merit Turizm Yatirim ve Isletme AS
IST:MERIT.E
|
TR |
|
Hexo Corp
TSX:HEXO
|
CA |
|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
CN |
Balance Sheet
Balance Sheet Decomposition
Neuroone Medical Technologies Corp
Neuroone Medical Technologies Corp
Balance Sheet Decomposition is not available for
Neuroone Medical Technologies Corp
Neuroone Medical Technologies Corp
Balance Sheet
Neuroone Medical Technologies Corp
Neuroone Medical Technologies Corp
Currency: USD
| Sep-2018 | Sep-2019 | Sep-2020 | Sep-2021 | Sep-2022 | Sep-2023 | Sep-2024 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
4
|
7
|
8
|
5
|
1
|
7
|
|
| Cash |
0
|
0
|
4
|
7
|
8
|
5
|
1
|
7
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
1
|
2
|
3
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
4
|
7
|
12
|
7
|
5
|
10
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
1
+141%
|
5
+798%
|
8
+67%
|
13
+61%
|
8
-37%
|
5
-34%
|
11
+101%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Accrued Liabilities |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Short-Term Debt |
2
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Total Current Liabilities |
4
|
2
|
2
|
1
|
3
|
2
|
2
|
2
|
|
| Long-Term Debt |
1
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
5
N/A
|
2
-62%
|
3
+52%
|
1
-49%
|
3
+133%
|
2
-43%
|
5
+146%
|
4
-18%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
10
|
17
|
31
|
41
|
51
|
63
|
75
|
79
|
|
| Additional Paid In Capital |
6
|
16
|
33
|
47
|
60
|
69
|
76
|
86
|
|
| Total Equity |
4
N/A
|
1
+72%
|
2
N/A
|
7
+216%
|
10
+47%
|
6
-35%
|
1
-87%
|
7
+760%
|
|
| Total Liabilities & Equity |
0
N/A
|
1
+141%
|
5
+798%
|
8
+67%
|
13
+61%
|
8
-37%
|
5
-34%
|
11
+101%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
3
|
5
|
7
|
12
|
16
|
24
|
31
|
50
|
|
Switch to:
Switch to:
See Also
Discover More
